Publication Name	World Journal of Hepatology
Manuscript ID	16629
Country	United States

Received	2015-01-25 19:52
Peer-Review Started	2015-01-26 15:49
To Make the First Decision	2015-03-06 10:10
Return for Revision	2015-03-15 18:10
Revised	2015-04-01 05:11
Second Decision	2015-06-24 17:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-07-02 16:32
Articles in Press	2015-07-02 16:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-06 18:22
Publish the Manuscript Online	2015-08-08 13:55

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Allergy
Manuscript Type	Review
Article Title	Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications
Manuscript Source	Invited Manuscript
All Author List	Peter Hauser and Shira Kern
Funding Agency and Grant Number
Corresponding Author	Peter Hauser, MD, VISN 22 Network Offices, 300 Oceangate Avenue, Suite 700, Long Beach, CA 90822, United States. peter.hauser2@va.gov
Key Words	Hepatitis C; Psychiatric disorders; Substance use disorders; Antiviral treatment
Core Tip	Hepatitis C viral (HCV) is among the most common blood-borne viral infections in the world. Although disease management strategies are often complicated by the high rate of psychiatric and sub-stance use disorders (SUDs) within this population, studies now indicate that neuropsychiatric side effects can be effectively managed during antiviral therapy and that individuals with pre-existing psychiatric and SUDs can be treated successfully and achieve sustained virologic response. Furthermore, the development of new medication options for the treatment of HCV has provided additional opportunities for treatment of people with HCV who have - or are at risk for - psychiatric illness.
Publish Date	2015-08-08 13:55
Citation	Hauser P, Kern S. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications. World J Hepatol 2015; 7(15): 1921-1935
URL	http://www.wjgnet.com/1948-5182/full/v7/i15/1921.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i15.1921

Full Article (PDF)	WJH-7-1921.pdf
Full Article (Word)	WJH-7-1921.doc
Manuscript File	16629-Review.docx
Answering Reviewers	16629-Answering reviewers.pdf
Audio Core Tip	16629-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16629-Conflict-of-interest statement.pdf
Copyright License Agreement	16629-Copyright assignment.pdf
Peer-review Report	16629-Peer-review(s).pdf
Scientific Misconduct Check	16629-Scientific misconduct check.pdf
Scientific Editor Work List	16629-Scientific editor work list.pdf